Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 426.60 1.32
Hindalco 144.70 0.00
Bhel 189.30 1.42
Larsen & 1377.30 2.48
Wipro Lt 525.00 1.19
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Dishman Pharmaceuticals & Chemicals Limited
Dishman Pharmaceuticals & Chemicals Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:532526NSE:DISHMANBloomberg:DISH@INReuters:DISH.BO
Market Lot: 1Face Value: 2ISIN Demat: INE353G01020
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
31-JUL-13 Dishman Pharmaceuticals & Chemicals announced a steep drop in consolidated net profit for the quarter ended June 2013. During the quarter, the profit of the company declined 24.43% to Rs 292.53 million from Rs 387.08 million in the same quarter last year. 03-JUL-13 Dishman Pharmaceuticals and Chemicals announced on Wednesday that Mark Griffiths is appointed as CEO of Dishman Group of companies, worldwide. 28-MAY-13 Dishman Pharmace...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Dishman Pharma jumps on strong Q2 earnings   -IRIS 01-Nov-13
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2013(9)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 3151.884835.814619.99
Other Income70.43135.92118.36
Total Income3222.314971.734738.35
Cost of goods sold2104.003170.863184.21
OPBDIT1118.311800.871554.14
PAT169.92631.75448.36
Gross Block---
Equity capital161.39161.39161.39
EPS (Rs.)-7.835.56
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-5.27 - 15.905.85 - 19.85
Debt / Equity (x)---
Operating margin (% of OI)34.736.232.8
Net margin (% of OI) 5.312.7 9.5
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Bhadr Raj Chambers
Swastik Cross Road
Navrangpura
Ahmedabad
Gujarat-380 009
PHONE
(079) 2644 3053/ 5807
FAX
(079) 2642 0198
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer